Santa Clara company whose Syncron-E software analyzes recorded ventilator waveforms and flags evidence of ineffective patient effort for respiratory therapists. FDA granted it De Novo authorization in July 2026, creating a new ventilator waveform analysis software category.
One email, every morning
THE MORNING BRIEF
New clearances, funding rounds and regulatory moves for device founders, and every new how-to guide and template as it lands. No noise, no login.
✓
You're in. The next morning brief lands in your inbox.
No Spam. Unsubscribe anytime.